Comparison of 30-Day and Long-Term Outcomes and Hospital Complications Among Patients Aged <75 Versus ≥75 Years With ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Guy Topaz(Tel Aviv University), Lior Yankelson(Tel Aviv University), Yaron Arbel(Tel Aviv Sourasky Medical Center), Nir Flint(Vita-Salute San Raffaele University), Shmuel Banai(Tel Aviv Sourasky Medical Center), Ariel Finkelstein, Yacov Shacham(Tel Aviv University), Gad Keren(Assuta Medical Center), Arie Steinvil(Tel Aviv University)
Cited by 19
Related Papers
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
|Journal of the American College of Cardiology|2000|731
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
|Journal of the American College of Cardiology|2001|646
Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography
|Atherosclerosis|2012|390
Role of Naturally Occurring CD4 <sup>+</sup> CD25 <sup>+</sup> Regulatory T Cells in Experimental Atherosclerosis
|Arteriosclerosis Thrombosis and Vascular Biology|2007|347